Long-term efficacy of radiofrequency ablation compared to surgical resection for the treatment of small hepatocellular carcinoma

Journal of B.U.ON.

Volumn 20, Issue 2, 2015, Pages 548-554

  Bu, Xiangyang ^a,b   Ge, Zhong ^b   Ma, Jian ^b   Guo, Shanyuan ^c   Wang, Yi ^b   Liu, Jun ^d  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c Department of Dentistry   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Surgical resection

Indexed keywords

ABDOMINAL BLEEDING; ADULT; ARTICLE; BONE METASTASIS; BURN; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LARGE CORE NEEDLE BIOPSY; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; LUNG CONGESTION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PLEURA EFFUSION; POSTOPERATIVE PAIN; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RETROSPECTIVE STUDY; SINUS BRADYCARDIA; SMALL CELL CARCINOMA; SURVIVAL TIME; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SURVIVOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVORS;

EID: 84930750229     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127.
2. Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 2012; 1:144-158.
3. Tabrizian P, Schwarz ME. Surgical management of hepatocellular carcinoma. Mt Sinai J Med 2012; 79:223-231.
4. Bryant R, Laurent A, Tayar C et al. Liver resection for hepatocellular carcinoma. Surg Oncol Clin N Am 2008; 17:607-633.
5. Mazzaferro V, Bhoori S, Sposito C et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011; 17:S44-57.
6. Lo GH. Updated management of hepatocellular carcinoma. Hepatology 2011; 54:1113.
7. Lencioni R. Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012; 1:41-50.
8. Tsochatzis EA, Germani G, Burroughs AK. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment Semin Oncol 2010; 37:89-93.
9. Huang GT, Liang JD, Sheu JC. Current role of local ablative treatments for hepatocellular carcinoma. J Formos Med Assoc 2004; 103:403-410.
10. Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012; 262:43-58.
11. Huang J, Hernandez-Alejandro R, Croome KP et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics - a retrospective study of 1, 061 cases. J Gastrointest Surg 2011; 15:311-320.
12. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321-328.
13. Molinari M, Helton S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg 2009; 198:396-406.
14. Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: surgery or ablation? Surgeon's perspective. J Hepatobiliary Pancreat Sci 2010; 17:422-424.
15. Hong SN, Lee SY, Choi MS et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39:247-252.
16. Vivarelli M, Guglielmi A, Ruzzenente A et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240:102-107.
17. Montorsi M, Santambrogio R, Bianchi P et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gantrointest Surg 2005; 9:62-67.
18. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249:20-25.
19. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78:113-124.
20. Ikeda K, Kobayashi M, Saitho S et al. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. Hepatol Res 2005; 33:241-249.
21. Mulier S, Ni Y, Jamart J et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242; 158-171.